Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
21.66
+0.64 (3.04%)
At close: Jun 12, 2026, 4:00 PM EDT
21.61
-0.05 (-0.23%)
After-hours: Jun 12, 2026, 7:53 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.44 billion as of June 12, 2026. Its market cap has increased by 74.77% in one year.
Market Cap
3.44B
Enterprise Value
2.43B
1-Year Change
74.77%
Ranking
Category
Stock Price
$21.66
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.44B, an increase of 82.16%. That is a compound annual growth rate of 7.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 3.44B | 41.97% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 3.66B |
| Edgewise Therapeutics | 3.65B |
| Crinetics Pharmaceuticals | 3.54B |
| NewAmsterdam Pharma Company | 3.54B |
| Viking Therapeutics | 3.32B |
| Telix Pharmaceuticals | 3.20B |
| Relay Therapeutics | 3.10B |
| Structure Therapeutics | 3.08B |